These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37960717)

  • 1. Assessing the efficacy and safety of Craniosacral therapy for migraine: A single center randomized controlled trial.
    Jiang G; Ma S; Zhao J; Zhang M; Li Y; Chen W; Cui L; Jia L
    Medicine (Baltimore); 2023 Nov; 102(45):e35431. PubMed ID: 37960717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Craniosacral therapy for migraine: protocol development for an exploratory controlled clinical trial.
    Mann JD; Faurot KR; Wilkinson L; Curtis P; Coeytaux RR; Suchindran C; Gaylord SA
    BMC Complement Altern Med; 2008 Jun; 8():28. PubMed ID: 18541041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
    Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Mindfulness Meditation vs Headache Education for Adults With Migraine: A Randomized Clinical Trial.
    Wells RE; O'Connell N; Pierce CR; Estave P; Penzien DB; Loder E; Zeidan F; Houle TT
    JAMA Intern Med; 2021 Mar; 181(3):317-328. PubMed ID: 33315046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is craniosacral therapy effective for migraine? Tested with HIT-6 Questionnaire.
    Arnadottir TS; Sigurdardottir AK
    Complement Ther Clin Pract; 2013 Feb; 19(1):11-4. PubMed ID: 23337558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.
    Aurora SK; Dodick DW; Diener HC; DeGryse RE; Turkel CC; Lipton RB; Silberstein SD
    Acta Neurol Scand; 2014 Jan; 129(1):61-70. PubMed ID: 24107267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Soft Tissue Techniques on Headache Impact, Disability, and Quality of Life in Migraine Sufferers: A Pilot Study.
    Espí-López GV; Ruescas-Nicolau MA; Nova-Redondo C; Benítez-Martínez JC; Dugailly PM; Falla D
    J Altern Complement Med; 2018 Nov; 24(11):1099-1107. PubMed ID: 29708766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Mindfulness-Based Cognitive Therapy for Migraine Reduce Migraine-Related Disability in People with Episodic and Chronic Migraine? A Phase 2b Pilot Randomized Clinical Trial.
    Seng EK; Singer AB; Metts C; Grinberg AS; Patel ZS; Marzouk M; Rosenberg L; Day M; Minen MT; Lipton RB; Buse DC
    Headache; 2019 Oct; 59(9):1448-1467. PubMed ID: 31557329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxins for the prevention of migraine in adults.
    Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives N; Clarke CE; Sinclair A
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD011616. PubMed ID: 29939406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment.
    Silberstein SD; Rapoport AM; Loupe PS; Aycardi E; McDonald M; Yang R; Bigal ME
    Headache; 2019 Mar; 59(3):383-393. PubMed ID: 30450545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA.
    Dodick DW; Goadsby PJ; Schwedt TJ; Lipton RB; Liu C; Lu K; Yu SY; Severt L; Finnegan M; Trugman JM
    Lancet; 2023 Dec; 402(10419):2307-2316. PubMed ID: 37979595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.
    Mulleners WM; Kim BK; Láinez MJA; Lanteri-Minet M; Pozo-Rosich P; Wang S; Tockhorn-Heidenreich A; Aurora SK; Nichols RM; Yunes-Medina L; Detke HC
    Lancet Neurol; 2020 Oct; 19(10):814-825. PubMed ID: 32949542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
    Mathew NT; Jaffri SF
    Headache; 2009; 49(10):1466-78. PubMed ID: 19912346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Controlled Pilot Trial of Behavioral Insomnia Treatment for Chronic Migraine With Comorbid Insomnia.
    Smitherman TA; Walters AB; Davis RE; Ambrose CE; Roland M; Houle TT; Rains JC
    Headache; 2016 Feb; 56(2):276-91. PubMed ID: 26813845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Credibility of low-strength static magnet therapy as an attention control intervention for a randomized controlled study of CranioSacral therapy for migraine headaches.
    Curtis P; Gaylord SA; Park J; Faurot KR; Coble R; Suchindran C; Coeytaux RR; Wilkinson L; Mann JD
    J Altern Complement Med; 2011 Aug; 17(8):711-21. PubMed ID: 21732734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial.
    Gross E; Putananickal N; Orsini AL; Schmidt S; Vogt DR; Cichon S; Sandor P; Fischer D
    Trials; 2019 Jan; 20(1):61. PubMed ID: 30654835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effect of electroacupuncture with different frequency on headache attacks in migraine outpatients: study protocol for a randomised placebo-controlled trial.
    Nie N; Chen L; Li T; Zhou C; Li B; Ji C; Zhou J; Chen Q; Li Q; Liang Y; Fang J
    Trials; 2021 Jul; 22(1):483. PubMed ID: 34301299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.